-
Something wrong with this record ?
Cetrorelix and Triptorelin active immunization influences follicle development and receptor expressions of ovaries in mice
Suocheng Wei, Zhuandi Gong, Lifeng An, Taojie Zhang, Fengwei Zhang, Shien Chen
Language English Country Czech Republic
- MeSH
- Enzyme-Linked Immunosorbent Assay methods utilization MeSH
- Animal Experimentation MeSH
- Financing, Organized MeSH
- Follicle Stimulating Hormone MeSH
- Gonadotropin-Releasing Hormone * antagonists & inhibitors therapeutic use MeSH
- Immunization * methods trends utilization MeSH
- Animals, Laboratory MeSH
- Luteinizing Hormone genetics drug effects MeSH
- Mice MeSH
- Ovarian Follicle cytology immunology drug effects MeSH
- Statistics as Topic MeSH
- Case-Control Studies MeSH
- Triptorelin Pamoate * administration & dosage therapeutic use MeSH
- Blotting, Western methods utilization MeSH
- Check Tag
- Mice MeSH
- Female MeSH
The study investigated comparatively the effects of active immunization of Cetrorelix and Triptorelin on the follicle development, histological structures, and expressions of FSHR and LHR proteins in the ovary. One hundred and five female mice, 35 days old, and body weight of 26.56 ± 2.89 g, were randomly assigned into Cetrorelix (CET), Triptorelin (TRI) and control groups (CG). Mice in CET-1, CET-2 and CET-3 (n = 15) were subcutaneously injected with 0.1, 0.2 and 0.4 mL Cetrorelix antigen (100 μg/mL) for seven days, respectively. Mice in TRI-1, TRI-2 and TRI-3 were injected with 0.1, 0.2 and 0.4 mL Triptorelin antigen (100 μg/mL) for seven days. Mice in CG (n = 15) were injected with 0.2 mL saline for seven days. Western blotting was utilized to determine the expressions of follicle stimulating hormone receptor (FSHR) and luteinizing hormone receptor (LHR) proteins. ELISA was used to measure the serum FSH and LH concentrations. The ovarian slices were observed under optical microscopy. The results showed that the ovarian weights of CET and TRI groups increased slightly with a maximum increment of 27.02% of CET-1 mice on day 35. Ovarian weights in TRI group increased dose-dependently with a maximum increment of 45.77% in TRI-3 on day 35. The numbers of the primordial follicle (POF), primary follicle (PF), secondary follicle (SF) and mature follicle (MF) of CET and TRI groups increased at different degrees when compared to CG. The granular layer in SF was arranged tightly and zona pellucida (ZP) was thickened. Follicles developed fully. Follicle longitudinal diameter (FLD), follicle transverse diameter (FTD) and follicle wall thickness (FWT) in CET and TRI groups increased as compared to CG. FLD, FTD and FWT of TRI-3 had a larger increment than CG and CET-1 on days 21 and 35. Expression levels of FSHR and LHR proteins in TRI group increased when compared to CG. Expression levels of FSHR and LHR proteins of CET group decreased. Serum FSH of TRI group was slightly higher than the CG and CET group on day 21. On day 35, serum FSH levels of CET-1 and TRI-1 were greater than CG and the rest of the subgroups. Serum FSH levels had no significant differences among all groups. Expression levels of LHR and FSHR proteins in CET group had obvious negative correlations to FLD, FTD and FWT. However, in the TRI group, these correlations were positive. In conclusion, Cetrorelix and Triptorelin immunization could improve ovarian growth, increase the follicle numbers, enhance dose-dependently the FLD, FTD and FWT, and eventually promote the ovary and follicle development. Cetrorelix decreased expression levels of FSHR and LHR proteins in the ovaries of mice. Triptorelin enhanced expression levels of FSHR and LHR proteins. Triptorelin treatment had more obvious effects than Cetrorelix treatment.
Life Science and Engineering College Northwest University for Nationalities Lanzhou China
Medicine College Northwest University for Nationalities Lanzhou China
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16015207
- 003
- CZ-PrNML
- 005
- 20160808184613.0
- 007
- ta
- 008
- 160524s2016 xr ad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jab.2015.06.003 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Wei, Suocheng $u Engineering & Technology Research Center of Animal Cells of Gansu Province, Northwest University for Nationalities, Lanzhou, China; Life Science and Engineering College, Northwest University for Nationalities, Lanzhou, China
- 245 10
- $a Cetrorelix and Triptorelin active immunization influences follicle development and receptor expressions of ovaries in mice / $c Suocheng Wei, Zhuandi Gong, Lifeng An, Taojie Zhang, Fengwei Zhang, Shien Chen
- 504 __
- $a Literatura
- 520 9_
- $a The study investigated comparatively the effects of active immunization of Cetrorelix and Triptorelin on the follicle development, histological structures, and expressions of FSHR and LHR proteins in the ovary. One hundred and five female mice, 35 days old, and body weight of 26.56 ± 2.89 g, were randomly assigned into Cetrorelix (CET), Triptorelin (TRI) and control groups (CG). Mice in CET-1, CET-2 and CET-3 (n = 15) were subcutaneously injected with 0.1, 0.2 and 0.4 mL Cetrorelix antigen (100 μg/mL) for seven days, respectively. Mice in TRI-1, TRI-2 and TRI-3 were injected with 0.1, 0.2 and 0.4 mL Triptorelin antigen (100 μg/mL) for seven days. Mice in CG (n = 15) were injected with 0.2 mL saline for seven days. Western blotting was utilized to determine the expressions of follicle stimulating hormone receptor (FSHR) and luteinizing hormone receptor (LHR) proteins. ELISA was used to measure the serum FSH and LH concentrations. The ovarian slices were observed under optical microscopy. The results showed that the ovarian weights of CET and TRI groups increased slightly with a maximum increment of 27.02% of CET-1 mice on day 35. Ovarian weights in TRI group increased dose-dependently with a maximum increment of 45.77% in TRI-3 on day 35. The numbers of the primordial follicle (POF), primary follicle (PF), secondary follicle (SF) and mature follicle (MF) of CET and TRI groups increased at different degrees when compared to CG. The granular layer in SF was arranged tightly and zona pellucida (ZP) was thickened. Follicles developed fully. Follicle longitudinal diameter (FLD), follicle transverse diameter (FTD) and follicle wall thickness (FWT) in CET and TRI groups increased as compared to CG. FLD, FTD and FWT of TRI-3 had a larger increment than CG and CET-1 on days 21 and 35. Expression levels of FSHR and LHR proteins in TRI group increased when compared to CG. Expression levels of FSHR and LHR proteins of CET group decreased. Serum FSH of TRI group was slightly higher than the CG and CET group on day 21. On day 35, serum FSH levels of CET-1 and TRI-1 were greater than CG and the rest of the subgroups. Serum FSH levels had no significant differences among all groups. Expression levels of LHR and FSHR proteins in CET group had obvious negative correlations to FLD, FTD and FWT. However, in the TRI group, these correlations were positive. In conclusion, Cetrorelix and Triptorelin immunization could improve ovarian growth, increase the follicle numbers, enhance dose-dependently the FLD, FTD and FWT, and eventually promote the ovary and follicle development. Cetrorelix decreased expression levels of FSHR and LHR proteins in the ovaries of mice. Triptorelin enhanced expression levels of FSHR and LHR proteins. Triptorelin treatment had more obvious effects than Cetrorelix treatment.
- 650 12
- $a triptorelin-pamoát $x aplikace a dávkování $x terapeutické užití $7 D017329
- 650 12
- $a hormon uvolňující gonadotropiny $x antagonisté a inhibitory $x terapeutické užití $7 D007987
- 650 _2
- $a folikuly stimulující hormon $7 D005640
- 650 12
- $a imunizace $x metody $x trendy $x využití $7 D007114
- 650 _2
- $a ovariální folikul $x cytologie $x imunologie $x účinky léků $7 D006080
- 650 _2
- $a luteinizační hormon $x genetika $x účinky léků $7 D007986
- 650 _2
- $a western blotting $x metody $x využití $7 D015153
- 650 _2
- $a ELISA $x metody $x využití $7 D004797
- 650 _2
- $a statistika jako téma $7 D013223
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a experimenty na zvířatech $7 D032761
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a laboratorní zvířata $7 D000830
- 650 _2
- $a studie případů a kontrol $7 D016022
- 700 1_
- $a Gong, Zhuandi $u Medicine College, Northwest University for Nationalities, Lanzhou, China
- 700 1_
- $a An, Lifeng $u Medicine College, Northwest University for Nationalities, Lanzhou, China $7 gn_A_00005789
- 700 1_
- $a Zhang, Taojie $u Life Science and Engineering College, Northwest University for Nationalities, Lanzhou, China
- 700 1_
- $a Zhang, Fengwei $u Life Science and Engineering College, Northwest University for Nationalities, Lanzhou, China
- 700 1_
- $a Chen, Shien $u Engineering & Technology Research Center of Animal Cells of Gansu Province, Northwest University for Nationalities, Lanzhou, China
- 773 0_
- $t Journal of applied biomedicine $x 1214-021X $g Roč. 14, č. 1 (2016), s. 49-57 $w MED00012667
- 856 41
- $u https://jab.zsf.jcu.cz/pdfs/jab/2016/01/06.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y 4 $z 0
- 990 __
- $a 20150522215938 $b ABA008
- 991 __
- $a 20160808184920 $b ABA008
- 999 __
- $a ok $b bmc $g 1125406 $s 939637
- BAS __
- $a 3
- BMC __
- $a 2016 $b 14 $c 1 $d 49-57 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
- LZP __
- $c NLK184 $d 20160808 $a NLK 2016-21/dk